Datavault AI Inc. (DVLT)
| Market Cap | 128.12M -38.7% |
| Revenue (ttm) | 46.86M +955.8% |
| Net Income | -173.47M |
| EPS | -0.39 |
| Shares Out | 949.73M |
| PE Ratio | n/a |
| Forward PE | 1.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,756,568 |
| Open | 0.1300 |
| Previous Close | 0.1333 |
| Day's Range | 0.1280 - 0.1397 |
| 52-Week Range | 0.1201 - 4.1000 |
| Beta | 0.35 |
| Analysts | Buy |
| Price Target | 2.50 (+1,753.23%) |
| Est. Earnings | Nov 16, 2026 |
About DVLT
Datavault AI Inc., a data sciences technology company, owns and operates data management platforms with high computing capabilities in North America, Asia Pacific, Europe, and internationally. The company is focused on the delivery of cyber-secure, privacy protected data management and monetization technologies, as well as offers artificial intelligence driven agents, such as Data Vault, DataValue, DataScore, and Data Vault Bank. It also offers wireless audio standards and data-over-sound technologies, creating solutions for audio experiences, ... [Read more]
Financial Performance
In 2025, Datavault AI's revenue was $39.09 million, an increase of 1361.82% compared to the previous year's $2.67 million. Losses were -$78.99 million, 16.6% more than in 2024.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for DVLT stock is "Buy." The 12-month stock price target is $2.5, which is an increase of 1,753.23% from the latest price.
News
Datavault signs non-binding LOI to acquire 19.9% stake in DataMEDS AI
Datavault AI (DVLT) announced that it has entered into a non-binding letter of intent to acquire a 19.9% equity interest in DataMEDS AI (MEDS) in consideration of an expansion of…
Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and r...
DataMEDS AI enters amended, restated LOI to license, acquire IP
DataMEDS AI (MEDS) has entered into an amended and restated non-binding letter of intent dated October 19 with Datavault (DVLT) AI, Data Health Partners’ wholly-owned subsidiary REBOOT Health AI, Inc....
Datavault AI Transcript: LD Micro 20th Annual Main Event Conference
An end-to-end data and real-world-asset tokenization platform is taking shape, with four exchanges live and roughly 14 contracts under contract. Priorities include completing fiat integration, advancing edge infrastructure, and navigating U.S. token rules.
DataMeds Regains Compliance With NASDAQ Listing Standards
TAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physica...
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market TAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc....
Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption
Allowed patent application covers asset valuation, tokenization, transaction verification, and blockchain-enabled marketplaces as a new federal framework opens the door to on-chain trading of tokenize...
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Platform to be integrated into Health Lives Here app as a subscription offering TAMPA, FL / ACCESS Newswire / October 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMED...
Datavault appoints Tirman to its Board of Directors
Datavault (DVLT) AI announced the appointment of Jeffrey Tirman to its Board of Directors, effective as of October 12, 2026. Tirman was designated by NYIAX in connection with Datavault AI’s…
Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Board of Directors
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and r...
Datavault AI to Debut Tort Token Capabilities at the Mass Torts Made Perfect Conference in Las Vegas
CEO Nathaniel T. Bradley to present on tokenization capabilities Today, October 13, at 3:45 p.m.
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx® Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL / AC...
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy TAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc . (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS...
Datavault AI to Attend the 2026 Maxim Growth Summit
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, digit...
Datavault appoints Christopher Hardt to board of directors
Datavault (DVLT) AI Iannounced the appointment of Christopher Hardt to its board of directors as an independent director. Hardt was designated by NYIAX in connection with Datavault AI’s recently compl...
Datavault AI Appoints Christopher R. Hardt as Independent Director Following NYIAX Acquisition
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, digit...
Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment
Healthcare IT Company and its Subsidiary Undertake Action Following US Government's Updated Nomenclature TAMPA, FL / ACCESS Newswire / October 5, 2026 / DataMeds AI, Inc . (NASDAQ:MEDS) ("DataMeds AI,...
Datavault AI CEO to Present "Operating System for Tokenized Assets" at XRP Seoul 2026
Session to debut the first official XRP Seoul commemorative token, powered by ADIO® tone-to-token technology, and demonstrate unified valuation, credentialing, and verified metadata for real-world ass...
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Datavault AI Inc. Lawsuit - DVLT
Time-Sensitive: Allegations Focus on Undisclosed Information Concerning Company Leadership NEW YORK, Oct. 1, 2026 /PRNewswire/ -- SueWallSt alerts investors in Datavault AI Inc. (NASDAQ: DVLT) of a pe...
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launches TAMPA, FL / ACCESS Newswire / October 1, 2...
DEADLINE NEXT WEEK: Berger Montague Advises Datavault AI Inc. (DVLT) Investors to Contact the Firm Before October 5, 2026
Philadelphia, Pennsylvania--(Newsfile Corp. - September 29, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Datavault AI Inc. (NASDAQ: DVLT) ("Datavau...
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services TAMPA, FL / ACCESS Newswire / September 28, 2026 / Data...
Robbins LLP Reminds Datavault AI Inc. Investors to Reach Out for Information About Recovering Their Losses Due to DVLT's Stock Drop
SAN DIEGO--(BUSINESS WIRE)---- $DVLT #DataManagement--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or ot...
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
Interim Co-CEO to Discuss Growing Patient Desire to Own Health Data TAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a ...
Kaplan Fox Reminds Datavault AI Inc. (NASDAQ: DVLT) Investors with Significant Losses to Seek a Leadership Role Before Deadline on October 5, 2026
NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Datavault AI Inc. (“Datavault” or the “Company”) (NASDAQ: DVLT) on...